ASAM Provider Guide

National Practice Guideline for the Treatment of Opioid Use Disorder - 2020 Update

ASAM Opioid Addiction Treatment GUIDELINES Apps and Pocket Guides brought to you courtesy of Guideline Central. Enjoy!

Issue link: http://eguideline.guidelinecentral.com/i/1224390

Contents of this Issue

Navigation

Page 29 of 29

Disclaimer is pocket guide attempts to define principles of practice that should produce high-quality patient care. It is applicable to specialists, primary care, and providers at all levels. is pocket guide should not be considered exclusive of other methods of care reasonably directed at obtaining the same results. e ultimate judgment concerning the propriety of any course of conduct must be made by the clinician aer consideration of each individual patient situation. Neither IGC, the medical associations, nor the authors endorse any product or service associated with the distributor of this clinical reference tool. Abbreviations AIDS, Acquired Immunodeficiency Syndrome; ASAM, American Society of Addiction Medicine; BP, blood pressure; DSM-5, Diagnostic and Statistical Manual of Mental Disorders, 5th Edition; FDA, Food and Drug Administration; HHS, U.S. Department of Health & Human Services; HIV, Human Immunodeficiency Virus; mL, milliliter; mg, milligram; NSAIDs, Non-Steroidal Anti-Inflammatory Drugs; OBOT, Office- Based Opioid Treatment; OTP, Opioid treatment program; OUD, Opioid use disorder; STI, Sexually transmitted infection; TB, Tuberculosis; UROD, Ultra-Rapid Opioid Detoxification; WM, withdrawal management; XR, extended release Source e ASAM National Practice Guideline for the Treatment of Opioid Use Disorder: 2020 Focused Update. Available at: https://www.asam.org/Quality-Science/quality/ 2020-national-practice-guideline 106 Commerce Street, Suite 105 Lake Mary, FL 32746 TEL: 407.878.7606 • FAX: 407.878.7611 Order additional copies at GuidelineCentral.com Copyright © 2020 All rights reserved ASAMOPI3203 Resources 1 e ASAM Criteria [https://www.asam.org/asam-criteria] 2 e ASAM Standards [https://www.asam.org/resources/quality/standards-and-performance-measures] 3 e ASAM Sample Diversion Control Policy [https://www.asam.org/docs/default-source/advocacy/sample-diversion-policy.pdf ] 4 e ASAM Appropriate Use of Drug Testing in Clinical Addiction Medicine [https://www.asam.org/Quality-Science/quality/drug-testing ] 5 e Prescription Drug Monitoring Program [https://www.cdc.gov/drugoverdose/pdmp/providers.html] 6 ASAM.GuidelineCentral.com for Calculators Guideline Committee Members Chinazo Cunningham, MD, MS, FASAM; Mark J. Edlund, MD, PhD; Marc Fishman, MD, DFASAM; Adam J. Gordon, MD, MPH, FACP, DFASAM; Hendrée E. Jones, PhD Kyle Kampman, MD, FASAM, Chair; Daniel Langleben, MD; Marjorie Meyer, MD Sandra Springer, MD, FASAM; George Woody, MD; Tricia E. Wright, MD, MS, FACOG, DFASAM; Stephen Wyatt, DO, FAOAAM, FASAM, Co-Chair

Articles in this issue

Links on this page

Archives of this issue

view archives of ASAM Provider Guide - National Practice Guideline for the Treatment of Opioid Use Disorder - 2020 Update